SG11201912149WA - Tetrahydropyridopyrazine Modulators Of GPR6 - Google Patents

Tetrahydropyridopyrazine Modulators Of GPR6

Info

Publication number
SG11201912149WA
SG11201912149WA SG11201912149WA SG11201912149WA SG11201912149WA SG 11201912149W A SG11201912149W A SG 11201912149WA SG 11201912149W A SG11201912149W A SG 11201912149WA SG 11201912149W A SG11201912149W A SG 11201912149WA SG 11201912149W A SG11201912149W A SG 11201912149WA
Authority
SG
Singapore
Prior art keywords
tetrahydropyridopyrazine
gpr6
modulators
tetrahydropyridopyrazine modulators
Prior art date
Application number
SG11201912149WA
Other languages
English (en)
Inventor
Jason W Brown
Stephen Hitchcock
Maria Hopkins
Shota Kikuchi
Holger Monenschein
Holly Reichard
Kristin Schleicher
Huikai Sun
Todd Macklin
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of SG11201912149WA publication Critical patent/SG11201912149WA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201912149WA 2017-06-15 2018-06-15 Tetrahydropyridopyrazine Modulators Of GPR6 SG11201912149WA (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762520430P 2017-06-15 2017-06-15
US201762591247P 2017-11-28 2017-11-28
US201862649856P 2018-03-29 2018-03-29
US201862672261P 2018-05-16 2018-05-16
PCT/US2018/037687 WO2018232202A1 (en) 2017-06-15 2018-06-15 Tetrahydropyridopyrazine modulators of gpr6

Publications (1)

Publication Number Publication Date
SG11201912149WA true SG11201912149WA (en) 2020-01-30

Family

ID=64656005

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201912149WA SG11201912149WA (en) 2017-06-15 2018-06-15 Tetrahydropyridopyrazine Modulators Of GPR6

Country Status (19)

Country Link
US (1) US10406157B2 (he)
EP (1) EP3638673B1 (he)
JP (2) JP7460369B2 (he)
KR (1) KR20200014796A (he)
CN (1) CN110730781B (he)
AU (1) AU2018285677B2 (he)
BR (1) BR112019026430A2 (he)
CA (1) CA3067032A1 (he)
CO (1) CO2019015086A2 (he)
DK (1) DK3638673T3 (he)
FI (1) FI3638673T3 (he)
IL (1) IL271332B2 (he)
JO (1) JOP20180057A1 (he)
LT (1) LT3638673T (he)
MX (1) MX2019014940A (he)
PH (1) PH12019502792A1 (he)
SG (1) SG11201912149WA (he)
TW (1) TWI775874B (he)
WO (1) WO2018232202A1 (he)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
US7229557B2 (en) * 2004-02-04 2007-06-12 Konec, Inc. Method to separate stereoisomers
EP2451281A4 (en) * 2009-07-09 2013-03-13 Merck Sharp & Dohme ANTAGONISTS OF OREXIN RECEPTORS BASED ON TETRAHYDRONAPHTHYRIDINE
JO3466B1 (ar) 2013-12-20 2020-07-05 Takeda Pharmaceuticals Co مواد ضابطة لتترا هيدرو بيريدوبيرازينات من gpr6
EP3105230B1 (en) 2014-02-14 2021-04-07 Takeda Pharmaceutical Company Limited Pyridopyrazines modulators of gpr6
AU2015218402B2 (en) * 2014-02-14 2019-07-11 Takeda Pharmaceutical Company Limited Pyrazines modulators of GPR6

Also Published As

Publication number Publication date
RU2019144408A (ru) 2021-07-15
CO2019015086A2 (es) 2020-04-13
CN110730781A (zh) 2020-01-24
PH12019502792A1 (en) 2020-09-14
CN110730781B (zh) 2023-05-05
IL271332B (he) 2022-10-01
JP2022188199A (ja) 2022-12-20
NZ759708A (en) 2024-04-26
EP3638673B1 (en) 2024-07-17
WO2018232202A1 (en) 2018-12-20
JP7497400B2 (ja) 2024-06-10
AU2018285677B2 (en) 2022-07-14
JOP20180057A1 (ar) 2019-01-30
FI3638673T3 (fi) 2024-09-13
JP2020523287A (ja) 2020-08-06
BR112019026430A2 (pt) 2020-07-14
DK3638673T3 (da) 2024-09-16
RU2019144408A3 (he) 2021-09-07
MX2019014940A (es) 2020-02-19
CA3067032A1 (en) 2018-12-20
AU2018285677A1 (en) 2019-12-19
LT3638673T (lt) 2024-09-10
IL271332B2 (he) 2023-02-01
IL271332A (he) 2020-01-30
US10406157B2 (en) 2019-09-10
TWI775874B (zh) 2022-09-01
JP7460369B2 (ja) 2024-04-02
KR20200014796A (ko) 2020-02-11
EP3638673A1 (en) 2020-04-22
TW201906844A (zh) 2019-02-16
EP3638673A4 (en) 2021-03-24
US20180360831A1 (en) 2018-12-20

Similar Documents

Publication Publication Date Title
IL283582A (he) מאפננים של ror – גמא
HK1256599A1 (zh) ROR-γ的調節劑
IL274369A (he) מאפנני מסלולים של לחץ משולב
IL259342B (he) מאפננים של קולטני כמוקין
HK1250999A1 (zh) Ror1-ror2結合的調節劑
IL274405A (he) מאפנני מסלולים של לחץ משולב
IL274368A (he) מאפנני מסלולים של לחץ משולב
IL274406A (he) מאפנני מסלולים של לחץ משולב
IL274367A (he) מאפנני מסלולים של לחץ משולב
IL272888A (he) שימושים של נגזרות פיפרידיניל-אינדול
GB201706477D0 (en) Modification of polypeptides
GB2600654B (en) Novel devices
IL268731A (he) שימושים חדשים של נוגדנים אנטי-sirpg
IL269409A (he) שילובי מעכבים chk1 ו-wee1
IL281492A (he) מודולטורים של ביטוי pnpla3
IL274627A (he) צורות מוצקות של ואלבנאזין
IL283967A (he) מודולטורים של ביטוי hsd17b13
IL266261A (he) מאפנני ror-gamma
GB201716468D0 (en) Modulators
ZA201606077B (en) Pyrazines modulators of gpr6
IL274231A (he) מאפננים של ביטוי enac
IL271359A (he) מאפננים של אלפא-סינוקלאין
IL247234A0 (he) מאפנני קספאז-6
GB2563095B (en) Modulators
IL271332B (he) מודולטורים טטרהידרופירידופירזינים של gpr6